Can digital technology really help to measure meaningful endpoints in clinical trials?

With the right conditions, it certainly can, concluded - with a resounding 'yes' - a December 2022 workshop of international stakeholders in clinical research. The workshop registered wide agreement on the promise of the rapidly increasing range of new digital health technology (DHT) that can ensure patients are fully at the centre of clinical trials. The participants, from the worlds of research, regulation, health technology assessment, patient organisations, industry and ethics committees, concurred that when these tools are adequately validated and used, they can produce more precise, relevant and sensitive measures to identify treatment effects sooner, in trials that are smaller, even allowing patients to take part in their own home. There was a perceptible sense of momentum for the future deriving from the last two decades of digitalization of clinical research. “We are all convinced that this is the right way to go to obtain patient-relevant data. The question is not if but when," as one participant in the workshop summed it up.

Download the event report